CAI International Inc. CAI is seeing excellent follow-through from last Friday, when price popped all the way up to a high of $26.12. On Monday the stock gained $1.00, or 3.8%, to close at a three-year high of $26.93 on 427,600 shares traded. Analysts have dramatically increased earnings expectations for the transportation finance and logistics company in recent weeks, and earnings will be announced on Wednesday (July 26) after the close. The stock is being traded at some of the heaviest volume this year. Having already blown through significant resistance in the $25-$26 zone, price could easily reach $30 in the near term. The price channel shows that this could be a $40 stock or more in the longer term.
ImmunoGen, Inc. IMGN snapped back Monday, up $6.34, up 68 cents, or 12%, on 4.3 million shares traded. The stock bounced off the bottom of its rising channel as well as its 50-day moving average after having pulled back from its channel top in the last three weeks. The move came on no apparent news, although the company announces 2Q earnings this coming Friday morning. With continued momentum, price could move up to $8-$10 in the next few weeks.
Impex Laboratories Inc IPXL is on the move, having recently broken out of a head-and-shoulders bottoming pattern. The stock closed at $18.75, up 60 cents, or 3.3%, on 1.5 million shares traded and no news, and is now up more than 40% off its mid-June low of $13.25. The stock saw large gains last week with news of FDA approval of a generic version of its ADHD drug, Concerta, and expected product launch by the end of 2017. The company is expected to report earnings on August 8 before market open. The next target range is $20-$23.
Kronos Worldwide, Inc. KRO broke out of its bull wedge consolidation pattern, gaining 54 cents, or 2.6%, on 456,000 shares traded Monday. Price for the chemicals manufacturing stock has not been up at this level in about five years. Watch the spike high price from July 12 at $21.10. If price moves through that level, targets going forward are $23.50 and $25.
See Harry's video chart analysis on these stocks.
No holdings.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
